Julio Delgado

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Vı́ctor Quesada, Laura Peña Conde, Neus Villamor et al. · Nature Genetics · 2011 · 988 citations · Full text

Somatic Variant, Chronic Lymphocytic Leukemia, Genetics +8

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Xosé S. Puente, Rafael Valdés‐Mas, Neus Villamor et al. · Nature · 2015 · 842 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +6

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Ian W. Flinn, Peter Hillmen, Marco Montillo et al. · Blood · 2018 · 331 citations · Full text

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

Ferran Nadeu, Julio Delgado, Cristina Royo et al. · Blood · 2016 · 327 citations · Full text